MSTR Wave Count: The $114 Target Explained
1 extracted signal · 0 resolved · 1 still active
MCO Global US Independent analyst profile- Source published
- 15 Sept 2026, 20:19 UTC
- Recorded by Tahlil Plus
- 15 Sept 2026, 23:25 UTC

AI-generated source summary
The analysis focuses on MicroStrategy (MSTR) as it encountered resistance from a defined micro resistance zone between $136.23 and $143.78. This zone was previously identified as resistance last week when the price tested the 23.6% Fibonacci retracement level at $129.72. The current analysis frames the price action as a corrective ABC move, suggesting that a C wave decline could begin from the current region. This is supported by an initial decline observed on Thursday last week, which marked a low at $129.72. The idea is that after this initial A wave down, the market might bounce into resistance before potentially continuing its downward trajectory as part of a larger corrective pattern. The identified resistance zone, therefore, represents a potential shorting opportunity if the price fails to break above it. The timeframe for this analysis appears to be a short to medium term, with the 4-hour chart being used for observation.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
MCO Global US
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
